Biosynex SA (FR:ALBIO) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Biosynex’s subsidiary, Chembio Diagnostics, has received a $1.5 million grant from the Bill & Melinda Gates Foundation to develop a rapid diagnostic test for congenital syphilis, a growing global health concern. The test aims to offer a quick, accurate, and affordable solution, particularly in low and middle-income regions, enhancing early diagnosis and treatment of syphilis in newborns and pregnant individuals.
For further insights into FR:ALBIO stock, check out TipRanks’ Stock Analysis page.